Skip to content

Trust Game and Placebo Response

Trust Game and Placebo Response

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02578212
Enrollment
106
Registered
2015-10-16
Start date
2015-01-31
Completion date
2016-03-31
Last updated
2016-04-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pain, Placebo Effect, Trust

Brief summary

In the proposed study, investigators aim to investigate the role of interpersonal trust in the conditioned placebo analgesia process with healthy male subjects in a standardized experimental heat pain paradigm.

Interventions

OTHERPlacebo

Sponsors

University Hospital, Basel, Switzerland
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
BASIC_SCIENCE
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
MALE
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Men: age between 18 and 40 years old * Healthy by self-report statement, thus no known current or chronic somatic diseases or psychiatric disorders * Right-handedness (Oldfield, 1971) * Willing to participate in study

Exclusion criteria

* Any acute or chronic disease (chronic pain, hypertension, heart disease, renal disease, liver disease, diabetes) as well as skin pathologies, neuropathies or nerve entrapment symptoms, sensory abnormalities affecting the tactile or thermal modality * Current medications (psychoactive medication, narcotics, intake of analgesics) or being currently in psychological or psychiatric treatment * Insufficient German language skills to understand the instructions * Previous participation in studies using pain assessment (threshold and tolerance) with Peltier Devices * Daily consumption of more than three alcoholic standard beverages per day (a standard alcoholic beverage is defined as either 3dl beer or 1 dl wine or 2cl spirits * Current or regular drug consumption (THC, cocaine, heroin, etc.)

Design outcomes

Primary

MeasureTime frame
Visual analogue scale (VAS) rating (Intensity + unpleasantness of pain)2 hours

Secondary

MeasureTime frame
State-Trait-Anxiety (STAI- X1)2 hours
State Trait Anger Expression (STAXI)2 hours
Questionnaire about expectations (Erwartungsfragebogen)2 hours
Visual analogue scale (VAS) rating (trust)2 hours
sociodemographic questionnaire (Soziodemographischer Fragebogen (SES))2 hours
Questionnaire about Self-assessment of partnership binding (Bochumer Bindungsfragebogen - BoBi)2 hours
State-Trait-Anxiety (STAI-X2 )2 hours
Questionnaire about the investigator (Fragebogen zum Versuchsleiter2 hours

Countries

Switzerland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026